Company intelligence / Profile preview

DermaSensor

Miami, Florida, United Statesdermasensor.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

The DermaSensor device has demonstrated high sensitivity and specificity for detecting malignant skin lesions in primary care settings. In a published study, it achieved a sensitivity of 90% and negative predictive value of nearly 99%, outperforming standard clinician management for early skin cancer detection. Over fifteen development and validation studies have been conducted with more than five thousand lesions assessed. The product received FDA clearance following successful pivotal trials meeting all primary endpoints.

Therapeutic areas: Dermatology
Modalities: DeviceArtificial intelligence-based diagnostic toolOptical spectroscopy (Elastic Scattering Spectroscopy)
Industry: Medical Imaging

Drug pipeline

1 asset

DermTech Melanoma Test

Commercial

Indications: Melanoma

Partnerships

TRG (The Reimbursement Group), providing reimbursement guidance to clinicians using the device

Beyond the preview

Go deeper on DermaSensor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DermaSensor.

Explore the full profile